Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
A man vaping. Photo: Justin Sullivan/Getty Images
Pax Labs, the marijuana vaporizer company that spun out Juul in 2017, is raising a small amount of new funding at a valuation of between $500 million and $600 million. It's unclear if this is a new series of stock or an extension of Pax's insider round from last October.
The big picture: Several of the investors are expected to be new, including a number of professional athletes. That last part could prove tricky, given the marijuana usage rules of most U.S. professional sports leagues. The company, which didn't respond to a request for comment, also is telling prospective investors that it plans to raise a $100 million round later this year at a valuation north of $1 billion.
Go deeper: Sin industries like marijuana and sports betting could shine in 2019